Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
Influenza viruses are characterized by their rapid antigenic change as a result of their high mutation frequency. Therefore, the composition of influenza virus vaccines requires frequent updates (every 2 years on average for H3N2) to match their antigenicity as closely as possible to that of the variant viruses most prevalent in the population. Analysis of antibody responses that correlate with protective immunity to influenza virus vaccination is an important element in the assessment of the potential impact of viral antigenic drift. The hemagglutination inhibition (HI) test is the most widely used serological test for the detection of anti-influenza virus antibodies and is used routinely to determine the serological outcome of vaccinations.